Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Results 1 - 15 of about 15 for valeant
Company Exchange Symbol Last price Quote change Market cap
Valeant Pharmaceuticals Intl Inc TSE VRX 145.25 -4.13 (-2.76%) 48.43B
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, ...
Valeant Pharmaceuticals Intl Inc NYSE VRX 133.23 -2.18 (-1.61%) 44.42B
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, ...
VALEANT PHARMA.INTL (NEW) FRA BVF 96.76 +0.19 (0.20%)
Cortex Pharmaceuticals OTCMKTS CORX 0.0320 0.0000 (0.00%) 4.61M
Cortex Pharmaceuticals, Inc. (Cortex) is engaged in the discovery and development of pharmaceuticals for the treatment of breathing disorders, ...
CORTEX PHARM. DL-,001 FRA PHX 0.009
Actavis PLC Private
Actavis PLC is a global, integrated specialty pharmaceutical company. The Company focused on developing, manufacturing and distributing generic, ...
Dr. Reddy's Laboratories Limited (ADR) NYSE RDY 43.11 +0.36 (0.84%) 7.33B
Dr. Reddy's Laboratories Limited (DRL) is an integrated global pharmaceutical company. The Company operates in three segments: Global Generics segment, ...
Dr. Reddy's Laboratories Limited NSE DRREDDY 2,565.00 +12.40 (0.49%) 436.33B
Dr. Reddy's Laboratories Limited (DRL) is an integrated global pharmaceutical company. The Company operates in three segments: Global Generics segment, ...
Dr. Reddy's Laboratories Limited BOM 500124 2,565.45 +12.75 (0.50%) 436.41B
Dr. Reddy's Laboratories Limited (DRL) is an integrated global pharmaceutical company. The Company operates in three segments: Global Generics segment, ...
ACTAVIS INC. DL-,0033 FRA WAP1 106.36
DR REDDYS LABS ADR/1 IR 5 FRA RDDA 30.45 +0.04 (0.12%)
Zogenix, Inc. NASDAQ ZGNX 2.81 -0.20 (-6.64%) 392.11M
Zogenix, Inc. (Zogenix) is a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain.
Nektar Therapeutics NASDAQ NKTR 11.96 -0.30 (-2.45%) 1.51B
Nektar Therapeutics is a clinical-stage biopharmaceutical company which develops a pipeline of drug candidates that utilize company platforms.
NEKTAR THERAPEUTICS FRA ITH 8.84 +0.88 (11.00%)
ZOGENIX INC. DL-,001 FRA Z08 2.14 +0.01 (0.47%)